Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic condition that causes inflammation and ulcers in the lining of the colon, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis: TAK-279 Oral Medication
We are testing the effectiveness of TAK-279 for people with moderately to severely active ulcerative colitis. The study aims to see if it helps achieve remission and improves symptoms compared to a placebo.
1-2 years11-15 visitsEfficacy phase (II)Post-Trial Drug AccessCost ReimbursementInvestigational MedicinesOralGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a diagnosis of ulcerative colitis (UC)?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 60 days?
- Are you taking any medications for UC, such as corticosteroids or biologics?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zasocitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Gastroenterology and hepatology
Heverlee, Belgium
Hopital Erasme
Gastroenterology
Negenmanneke, Belgium
University Multiprofile Hospital For Active Treatment Kaspela EOOD
Gastroenterology clinic
Plovdiv, Bulgaria
Sponsor: Takeda Development Center Americas Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.